Literature DB >> 26898331

TGF-β Tumor Suppression through a Lethal EMT.

Charles J David1, Yun-Han Huang1, Mo Chen2, Jie Su1, Yilong Zou1, Nabeel Bardeesy3, Christine A Iacobuzio-Donahue4, Joan Massagué5.   

Abstract

TGF-β signaling can be pro-tumorigenic or tumor suppressive. We investigated this duality in pancreatic ductal adenocarcinoma (PDA), which, with other gastrointestinal cancers, exhibits frequent inactivation of the TGF-β mediator Smad4. We show that TGF-β induces an epithelial-mesenchymal transition (EMT), generally considered a pro-tumorigenic event. However, in TGF-β-sensitive PDA cells, EMT becomes lethal by converting TGF-β-induced Sox4 from an enforcer of tumorigenesis into a promoter of apoptosis. This is the result of an EMT-linked remodeling of the cellular transcription factor landscape, including the repression of the gastrointestinal lineage-master regulator Klf5. Klf5 cooperates with Sox4 in oncogenesis and prevents Sox4-induced apoptosis. Smad4 is required for EMT but dispensable for Sox4 induction by TGF-β. TGF-β-induced Sox4 is thus geared to bolster progenitor identity, whereas simultaneous Smad4-dependent EMT strips Sox4 of an essential partner in oncogenesis. Our work demonstrates that TGF-β tumor suppression functions through an EMT-mediated disruption of a lineage-specific transcriptional network.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26898331      PMCID: PMC4801341          DOI: 10.1016/j.cell.2016.01.009

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  63 in total

1.  KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.

Authors:  Baotong Zhang; Zhiqian Zhang; Siyuan Xia; Changsheng Xing; Xinpei Ci; Xin Li; Ranran Zhao; Sha Tian; Gui Ma; Zhengmao Zhu; Liya Fu; Jin-Tang Dong
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

2.  A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).

Authors:  Agnieszka B Bialkowska; Yang Liu; Mandayam O Nandan; Vincent W Yang
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

3.  Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

Authors:  Hector Peinado; Miguel Quintanilla; Amparo Cano
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

4.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

5.  Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.

Authors:  A Gal; T Sjöblom; L Fedorova; S Imreh; H Beug; A Moustakas
Journal:  Oncogene       Date:  2007-08-27       Impact factor: 9.867

6.  Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.

Authors:  R H Chen; Y H Su; R L Chuang; T Y Chang
Journal:  Oncogene       Date:  1998-10-15       Impact factor: 9.867

7.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

8.  Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

Authors:  Enza Lonardo; Patrick C Hermann; Maria-Theresa Mueller; Stephan Huber; Anamaria Balic; Irene Miranda-Lorenzo; Sladjana Zagorac; Sonia Alcala; Iker Rodriguez-Arabaolaza; Juan Carlos Ramirez; Raul Torres-Ruíz; Elena Garcia; Manuel Hidalgo; David Álvaro Cebrián; Rainer Heuchel; Matthias Löhr; Frank Berger; Peter Bartenstein; Alexandra Aicher; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

9.  Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.

Authors:  Hong Zhang; Meritxell Alberich-Jorda; Giovanni Amabile; Henry Yang; Philipp B Staber; Annalisa Di Ruscio; Annalisa Diruscio; Robert S Welner; Alexander Ebralidze; Junyan Zhang; Elena Levantini; Véronique Lefebvre; Peter J M Valk; Ruud Delwel; Maarten Hoogenkamp; Claus Nerlov; Jörg Cammenga; Borja Saez; David T Scadden; Constanze Bonifer; Min Ye; Daniel G Tenen
Journal:  Cancer Cell       Date:  2013-10-31       Impact factor: 31.743

10.  Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8).

Authors:  Neha Tiwari; Nathalie Meyer-Schaller; Phil Arnold; Helena Antoniadis; Mikhail Pachkov; Erik van Nimwegen; Gerhard Christofori
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  209 in total

1.  TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.

Authors:  Chen Liang; Jin Xu; Qingcai Meng; Bo Zhang; Jiang Liu; Jie Hua; Yiyin Zhang; Si Shi; Xianjun Yu
Journal:  Autophagy       Date:  2019-06-17       Impact factor: 16.016

Review 2.  SP and KLF Transcription Factors in Digestive Physiology and Diseases.

Authors:  Chang-Kyung Kim; Ping He; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Gastroenterology       Date:  2017-03-30       Impact factor: 22.682

3.  TGF-β Conveys Undesirable Side Effects of Androgen Depletion.

Authors:  Natasha Kyprianou
Journal:  Endocrinology       Date:  2016-11       Impact factor: 4.736

4.  SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Authors:  Hiroyuki Ozawa; Ruchira S Ranaweera; Evgeny Izumchenko; Eugene Makarev; Alex Zhavoronkov; Elana J Fertig; Jason D Howard; Ana Markovic; Atul Bedi; Rajani Ravi; Jimena Perez; Quynh-Thu Le; Christina S Kong; Richard C Jordan; Hao Wang; Hyunseok Kang; Harry Quon; David Sidransky; Christine H Chung
Journal:  Clin Cancer Res       Date:  2017-05-18       Impact factor: 12.531

Review 5.  The role of autophagy in morphogenesis and stem cell maintenance.

Authors:  Eric Bekoe Offei; Xuesong Yang; Beate Brand-Saberi
Journal:  Histochem Cell Biol       Date:  2018-10-31       Impact factor: 4.304

6.  PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.

Authors:  Ariel L Hernandez; Christian D Young; Li Bian; Kelsey Weigel; Kyle Nolan; Barbara Frederick; Gangwen Han; Guanting He; G Devon Trahan; Michael C Rudolph; Kenneth L Jones; Ayman J Oweida; Sana D Karam; David Raben; Xiao-Jing Wang
Journal:  Clin Cancer Res       Date:  2020-03-05       Impact factor: 12.531

7.  YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.

Authors:  Jixiang Chen; Yaocheng Sun; Xiao Xu; Dawei Wang; Junbo He; Hailang Zhou; Ying Lu; Jian Zeng; Fengyi Du; Aihua Gong; Min Xu
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

8.  A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.

Authors:  Wanbin Yang; Xiuli Gong; Xiulian Wang; Chao Huang
Journal:  Invest New Drugs       Date:  2018-11-29       Impact factor: 3.850

9.  Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.

Authors:  Alessandro Prete; Agnes S Lo; Peter M Sadow; Swati S Bhasin; Zeus A Antonello; Danica M Vodopivec; Soumya Ullas; Jennifer N Sims; John Clohessy; Ann M Dvorak; Tracey Sciuto; Manoj Bhasin; Joanne E Murphy-Ullrich; Jack Lawler; S Ananth Karumanchi; Carmelo Nucera
Journal:  Clin Cancer Res       Date:  2018-08-03       Impact factor: 12.531

10.  CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.

Authors:  Qiao Wu; Changying Fu; Menglin Li; Juan Li; Zhigui Li; Leilei Qi; Xinpei Ci; Gui Ma; Ang Gao; Xing Fu; Jun A; Na An; Mingcheng Liu; Yixiang Li; Jamie L King; Liya Fu; Baotong Zhang; Jin-Tang Dong
Journal:  Int J Cancer       Date:  2018-10-26       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.